title: Saccharomyces cerevisiae multidrug resistance gene expression inversely correlates with the status of the F(0) component of the mitochondrial ATPase.
abstract: Loss of the mitochondrial genome (rho(0) cell) or elimination of the mitochondrial inner membrane protein Oxa1p causes a dramatic increase in expression of the ATP binding cassette transporter-encoding gene PDR5 in the yeast Saccharomyces cerevisiae. This increase in gene expression occurs via activation of the function of the Cys(6)-Zn(II)(2) cluster transcription factor Pdr3p, which in turn autoregulates expression of its structural gene. Surprisingly, the acquisition of PDR5-dependent multidrug resistance occurs at a very high frequency, consistent with the appearance of rho(-) cells in a fermentatively growing culture (approximately 2%). The degree of activation of Pdr3p target genes was found to vary considerably and to be influenced by the presence of the homologous protein, Pdr1p. Mutagenesis and overexpression studies provided evidence that the control of Pdr3p expression was the major control point of this transcription factor by mitochondrial retrograde signaling. Because both rho(0) and oxa1 mutant cells have multiple defects including loss of normal respiratory chain function and oxidative phosphorylation, a series of mutant strains with more selective defects in mitochondrial function was employed to identify the molecular signal that triggers PDR5 transcriptional activation. Only mutations that influenced the functional status of the F(0) subunit of the mitochondrial ATPase were found to lead to activation of PDR5 expression.
authors.affiliation: Molecular Biology Ph.D. Program, University of Iowa, Iowa City, Iowa 52242, USA.
authors.forename: X
authors.initials: X
authors.lastname: Zhang
authors.forename: W S
authors.initials: WS
authors.lastname: Moye-Rowley
mesh_terms: D018528:ATP-Binding Cassette Transporters / Q000235:genetics*; D049069:ATP-Dependent Proteases; D000251:Adenosine Triphosphatases / Q000235:genetics; D001483:Base Sequence; D003513:Cycloheximide / Q000494:pharmacology; D017931:DNA Primers; D004268:DNA-Binding Proteins / Q000235:genetics*; D018432:Drug Resistance, Multiple / Q000235:genetics*; D017353:Gene Deletion; D005800:Genes, Fungal; D008565:Membrane Proteins / Q000235:genetics*; D011401:Promoter Regions, Genetic; D006180:Proton-Translocating ATPases / Q000378:metabolism*; D012441:Saccharomyces cerevisiae / Q000235:genetics*; D029701:Saccharomyces cerevisiae Proteins; D014157:Transcription Factors / Q000235:genetics*
chemical_list: D018528:ATP-Binding Cassette Transporters; D017931:DNA Primers; D004268:DNA-Binding Proteins; D008565:Membrane Proteins; C089261:PDR3 protein, S cerevisiae; C092438:PDR5 protein, S cerevisiae; D029701:Saccharomyces cerevisiae Proteins; D014157:Transcription Factors; D003513:Cycloheximide; D049069:ATP-Dependent Proteases; C082702:YME1 protein, S cerevisiae; D000251:Adenosine Triphosphatases; D006180:Proton-Translocating ATPases